News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Policy
Boston Scientific Corporation Heart Device Won’t Get Quick Review From FDA
March 26, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
WSJ -- Regulators on Thursday said they won't speed up the review of manufacturing changes required for Boston Scientific Corp. to resume selling its implantable heart defibrillators.
Twitter
LinkedIn
Facebook
Email
Print
Regulatory
MORE ON THIS TOPIC
China
Trump Reportedly Preparing Order Restricting Chinese Drug Licensing Deals
September 11, 2025
·
2 min read
·
Dan Samorodnitsky
Pain
FDA Looks To Streamline Development of Non-Opioid Painkillers
September 11, 2025
·
2 min read
·
Tristan Manalac
CDC
Ousted CDC Director Monarez to Testify In Front of Senate After RFK Jr. Clash
September 10, 2025
·
2 min read
·
Tristan Manalac
Podcast
Unpacking the Latest MAHA Report, RFK’s Senate Appearance, FDA’s CRL Drop and More
September 10, 2025
·
1 min read
·
Jef Akst
